The human sulfatase 2 inhibitor 2,4-disulfonylphenyl-tert-butylnitrone (OKN-007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1/SMAD2 and Hedgehog/GLI1 signaling
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The human sulfatase 2 inhibitor 2,4-disulfonylphenyl-tert-butylnitrone (OKN-007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1/SMAD2 and Hedgehog/GLI1 signaling
Authors
Keywords
-
Journal
GENES CHROMOSOMES & CANCER
Volume 52, Issue 3, Pages 225-236
Publisher
Wiley
Online
2012-10-30
DOI
10.1002/gcc.22022
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-Cancer Activity of Nitrones and Observations on Mechanism of Action
- (2012) Robert A. Floyd et al. Anti-Cancer Agents in Medicinal Chemistry
- Hepatocellular Carcinoma
- (2011) Nuh N. Rahbari et al. ANNALS OF SURGERY
- Effects of PBN and OKN007 in rodent glioma models assessed by 1H MR spectroscopy
- (2011) Ting He et al. FREE RADICAL BIOLOGY AND MEDICINE
- SULFs in human neoplasia: implication as progression and prognosis factors
- (2011) Caroline Bret et al. Journal of Translational Medicine
- Novel molecular therapies in hepatocellular carcinoma
- (2011) Sandrine Faivre et al. LIVER INTERNATIONAL
- hSulf-1 Gene Exhibits Anticancer Efficacy through Negatively Regulating VEGFR-2 Signaling in Human Cancers
- (2011) Weidan Ji et al. PLoS One
- Translational Stroke Research of the Combination of Thrombolysis and Antioxidant Therapy
- (2011) Sergio Amaro et al. STROKE
- Glucosamine-6-sulfamate Analogues of Heparan Sulfate as Inhibitors of Endosulfatases
- (2010) Mathias Schelwies et al. CHEMBIOCHEM
- Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate
- (2010) Steven D Rosen et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Sulfatase 1 and sulfatase 2 in hepatocellular carcinoma: Associated signaling pathways, tumor phenotypes, and survival
- (2010) Ju Dong Yang et al. GENES CHROMOSOMES & CANCER
- The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation
- (2010) Jin-Ping Lai et al. HEPATOLOGY
- Multiparametric assessment of the anti-glioma properties of OKN007 by magnetic resonance imaging
- (2010) Philippe Garteiser et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors
- (2010) Jin-Ping Lai et al. LIVER INTERNATIONAL
- The role of signaling pathways in the development and treatment of hepatocellular carcinoma
- (2010) S Whittaker et al. ONCOGENE
- Pharmacokinetics of 8-hour intravenous infusion of NXY-059: A phase I, randomized, double-blind (within dose panels), placebo-controlled study in healthy Chinese volunteers
- (2009) Yi-Fang Cheng et al. CLINICAL THERAPEUTICS
- Primary liver tumors: origin and target therapy
- (2009) Michail Papoulas et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Molecular targeted therapy for hepatocellular carcinoma
- (2009) Melanie Thomas JOURNAL OF GASTROENTEROLOGY
- Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis
- (2009) H Lemjabbar-Alaoui et al. ONCOGENE
- Factors Associated With Intracerebral Hemorrhage After Thrombolytic Therapy for Ischemic Stroke
- (2009) Brett Cucchiara et al. STROKE
- Systemic therapy of hepatocellular carcinoma: Are we making progress?
- (2008) Patricia Roxburgh et al. ADVANCES IN THERAPY
- Nitrones as therapeutics
- (2008) Robert A. Floyd et al. FREE RADICAL BIOLOGY AND MEDICINE
- Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma
- (2008) Jin-Ping Lai et al. HEPATOLOGY
- NXY-059 for the Treatment of Acute Stroke
- (2008) Hans-Christoph Diener et al. STROKE
- Treatment options for hepatocellular carcinoma
- (2008) Dalbir S Sandhu et al. Expert Review of Gastroenterology & Hepatology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search